End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.94 CNY | -2.57% | -10.96% | -14.71% |
Mar. 01 | BGI Genomics' 2023 Profit Falls 89% as Revenue Plunges 38% | MT |
Feb. 29 | BGI Genomics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Integrated Solutions for Precision Medical Testing
35.5
%
| 3,382 | 50.0 % | 2,504 | 35.5 % | -25.96% |
Infection Prevention and Control Basic Research and Clinical Application
32.7
%
| 1,158 | 17.1 % | 2,301 | 32.7 % | +98.65% |
Reproductive Health Basic Research and Clinical Application
15.8
%
| 1,192 | 17.6 % | 1,116 | 15.8 % | -6.44% |
Multi-omics Big Data Service and Synthetic
10.0
%
| 642 | 9.5 % | 705 | 10.0 % | +9.87% |
Tumor Prevention and Control and Translational Medicine
5.7
%
| 380 | 5.6 % | 404 | 5.7 % | +6.26% |
Other
0.2
%
| 12 | 0.2 % | 17 | 0.2 % | +41.94% |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
China (Excluding Hong Kong, Macau and Taiwan)
51.4
%
| 2,885 | 42.6 % | 3,622 | 51.4 % | +25.57% |
Asia (Including Hong Kong, Macau and Taiwan) and Oceania
39.6
%
| 2,511 | 37.1 % | 2,791 | 39.6 % | +11.15% |
Europe and Africa
5.5
%
| 939 | 13.9 % | 389 | 5.5 % | -58.61% |
Americas
3.5
%
| 432 | 6.4 % | 245 | 3.5 % | -43.37% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Li Jian Zhao
CEO | Chief Executive Officer | - | 21-06-15 |
Jian Hua Wang
FOU | Founder | 70 | - |
Yu Jue Wang
DFI | Director of Finance/CFO | 46 | 21-06-15 |
Yu Tao Du
COO | Chief Operating Officer | 47 | 18-06-18 |
Ye Yin
BRD | Director/Board Member | 45 | - |
Li Ping Ao
IRC | Investor Relations Contact | - | - |
Qian Xu
SEC | Corporate Secretary | 40 | 15-06-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Hua Wang
FOU | Founder | 70 | - |
Ye Yin
BRD | Director/Board Member | 45 | - |
- | - | ||
Wen Qi Li
BRD | Director/Board Member | 38 | 15-06-21 |
Yu Jie Hu
BRD | Director/Board Member | 40 | 15-06-21 |
Yu Tao Du
COO | Chief Operating Officer | 47 | 18-06-18 |
Lan Du
BRD | Director/Board Member | 48 | 21-08-12 |
Si Qi Liu
CHM | Chairman | 71 | 21-06-15 |
Ya Cao
BRD | Director/Board Member | 73 | 21-06-15 |
Li Jian Zhao
CEO | Chief Executive Officer | - | 21-06-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 413,914,325 | 215,943,776 ( 52.17 %) | 4,000,141 ( 0.9664 %) | 52.17 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,065,173 | 1.28% | 3,706,429 $ |
Company contact information
BGI Genomics Co., Ltd.
Huada Comprehensive Park Floor 7-14, Building 7
518083, Shenzhen
+
http://www.genomics.cnSector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.71% | 2.32B | |
-9.60% | 12.14B | |
+73.43% | 3.94B | |
-33.60% | 2.19B | |
-21.05% | 1.63B | |
+30.99% | 1.14B | |
+9.17% | 852M | |
-12.33% | 545M | |
-41.02% | 419M | |
+28.48% | 249M |
- Stock
- Equities
- Stock BGI Genomics Co., Ltd. - Shenzhen S.E.
- Company BGI Genomics Co., Ltd.